Entrada Therapeutics, Inc. (TRDA)
10.88
+0.08
(+0.74%)
USD |
NASDAQ |
Feb 13, 16:00
10.88
0.00 (0.00%)
After-Hours: 16:45
Entrada Therapeutics Shareholders Equity (Quarterly) : 340.72M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Kodiak Sciences, Inc. | 23.69M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Savara, Inc. | 94.39M |
| BioMarin Pharmaceutical, Inc. | 6.057B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 412.90M |
| Total Liabilities (Quarterly) | 72.18M |
| Debt to Equity Ratio | 0.1538 |
| Current Ratio | 14.08 |
| Net Debt Paydown Yield | 1.09% |